| Joshua David Bradley, MD | |
|
389 S 900 E, Salt Lake City, UT 84102-2310 | |
| (385) 282-2000 | |
| (385) 282-2001 |
| Full Name | Joshua David Bradley |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 22 Years |
| Location | 389 S 900 E, Salt Lake City, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366651671 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 6546952-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lds Hospital | Salt lake city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Scientists often study mice as a model for human biology and disease, because their basic biological processes are assumed to be essentially the same as those of humans.
Like a bad hangover that won't go away, some states are still suffering from the effects of the recession that technically ended three and half years ago. … Some states, including Iowa, Indiana and Tennessee, started the new session with surpluses, but none are planning to embark on new spending.
The National Cancer Center of South Korea and Velos, Inc. have entered into a seven year agreement to expand the use of Velos eResearch for cancer research nationally throughout South Korea and internationally in collaboration with other research partners.
Researchers at the Translational Genomics Research Institute (TGen) today announced the discovery of previously unrecognized alterations in a gene called FGFR2 in a subset of endometrial cancers, the most common gynecologic cancer in the United States.
Merck, known as MSD outside the United States and Canada, (NYSE: MRK) and Endocyte, Inc. (NASDAQ: ECYT) today announced the online publication of results from the randomized Phase II PRECEDENT trial for vintafolide (MK-8109/EC145), an investigational folate small molecule drug conjugate (SMDC), in the Journal of Clinical Oncology (JCO), the official journal of the American Society of Clinical Oncology.
› Verified 4 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Scientists often study mice as a model for human biology and disease, because their basic biological processes are assumed to be essentially the same as those of humans.
Like a bad hangover that won't go away, some states are still suffering from the effects of the recession that technically ended three and half years ago. … Some states, including Iowa, Indiana and Tennessee, started the new session with surpluses, but none are planning to embark on new spending.
The National Cancer Center of South Korea and Velos, Inc. have entered into a seven year agreement to expand the use of Velos eResearch for cancer research nationally throughout South Korea and internationally in collaboration with other research partners.
Researchers at the Translational Genomics Research Institute (TGen) today announced the discovery of previously unrecognized alterations in a gene called FGFR2 in a subset of endometrial cancers, the most common gynecologic cancer in the United States.
Merck, known as MSD outside the United States and Canada, (NYSE: MRK) and Endocyte, Inc. (NASDAQ: ECYT) today announced the online publication of results from the randomized Phase II PRECEDENT trial for vintafolide (MK-8109/EC145), an investigational folate small molecule drug conjugate (SMDC), in the Journal of Clinical Oncology (JCO), the official journal of the American Society of Clinical Oncology.
› Verified 4 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Scientists often study mice as a model for human biology and disease, because their basic biological processes are assumed to be essentially the same as those of humans.
Like a bad hangover that won't go away, some states are still suffering from the effects of the recession that technically ended three and half years ago. … Some states, including Iowa, Indiana and Tennessee, started the new session with surpluses, but none are planning to embark on new spending.
The National Cancer Center of South Korea and Velos, Inc. have entered into a seven year agreement to expand the use of Velos eResearch for cancer research nationally throughout South Korea and internationally in collaboration with other research partners.
Researchers at the Translational Genomics Research Institute (TGen) today announced the discovery of previously unrecognized alterations in a gene called FGFR2 in a subset of endometrial cancers, the most common gynecologic cancer in the United States.
Merck, known as MSD outside the United States and Canada, (NYSE: MRK) and Endocyte, Inc. (NASDAQ: ECYT) today announced the online publication of results from the randomized Phase II PRECEDENT trial for vintafolide (MK-8109/EC145), an investigational folate small molecule drug conjugate (SMDC), in the Journal of Clinical Oncology (JCO), the official journal of the American Society of Clinical Oncology.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joshua David Bradley, MD Po Box 30180, Salt Lake City, UT 84130-0180 Ph: (801) 656-9690 | Joshua David Bradley, MD 389 S 900 E, Salt Lake City, UT 84102-2310 Ph: (385) 282-2000 |
News Archive
Scientists often study mice as a model for human biology and disease, because their basic biological processes are assumed to be essentially the same as those of humans.
Like a bad hangover that won't go away, some states are still suffering from the effects of the recession that technically ended three and half years ago. … Some states, including Iowa, Indiana and Tennessee, started the new session with surpluses, but none are planning to embark on new spending.
The National Cancer Center of South Korea and Velos, Inc. have entered into a seven year agreement to expand the use of Velos eResearch for cancer research nationally throughout South Korea and internationally in collaboration with other research partners.
Researchers at the Translational Genomics Research Institute (TGen) today announced the discovery of previously unrecognized alterations in a gene called FGFR2 in a subset of endometrial cancers, the most common gynecologic cancer in the United States.
Merck, known as MSD outside the United States and Canada, (NYSE: MRK) and Endocyte, Inc. (NASDAQ: ECYT) today announced the online publication of results from the randomized Phase II PRECEDENT trial for vintafolide (MK-8109/EC145), an investigational folate small molecule drug conjugate (SMDC), in the Journal of Clinical Oncology (JCO), the official journal of the American Society of Clinical Oncology.
› Verified 4 days ago
Dr. Kendall M. Burgett, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-662-5663 | |
Dr. Jason P Hunt, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Russell Jon Ord, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 333 S 900 E, Salt Lake City, UT 84102 Phone: 801-535-8185 Fax: 801-355-4011 | |
Dr. David Parker Hill, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 2000 S 900 E, Salt Lake City, UT 84105 Phone: 801-464-7660 Fax: 801-464-7558 | |
Dr. Bethany R Powers, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6322 S 3000 E Ste 170, Salt Lake City, UT 84121 Phone: 801-513-3223 | |
Christopher A. Hamilton, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 50 North Medical Dr Som 3c120, Salt Lake City, UT 84132 Phone: 801-581-7514 | |
Quinn Taylor Orb, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Som 3c-120, Salt Lake City, UT 84132 Phone: 801-581-7514 Fax: 801-585-5744 |